Ted Maddess was supported by the Australian Research Council through the ARC Centre of Excellence in Vision Science (CE0561903).
In the interest of full disclosure we wish to mention that Maddess previously received royalty income from Carl Zeiss Meditec for the sale of the FDT/Matrix perimeters, but those royalties have now ceased, and this paper did not use those devices. Maddess and colleagues are also attempting to develop an objective perimeter.
The disclosures listed for that potential product are F, I, P, S, all to nuCoria Pty Ltd.
Disclosure: T. Numata, nuCoria Pty Ltd. (F, I, P, S); T. Maddess, Carl Zeiss Meditec (R); nuCoria Pty Ltd. (F, I, P, S); C. Matsumoto, nuCoria Pty Ltd. (F, I, P, S); S. Okuyama, nuCoria Pty Ltd. (F, I, P, S); S. Hashimoto, nuCoria Pty Ltd. (F, I, P, S); H. Nomoto, nuCoria Pty Ltd. (F, I, P, S); Y. Shimomura, nuCoria Pty Ltd. (F, I, P, S)